Rating History for Seres Therapeutics (MCRB) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for MCRB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/23/2026 Matthew Keller New Coverage Buy
(N/A)		 12.00
(N/A)		 6.60
(5.33)		 -19.24% Details